Cencora Announces Q2 2026 Earnings Release Date

Pharmaceutical solutions company schedules conference call to discuss quarterly results.

Apr. 2, 2026 at 7:22am

Cencora, Inc., a leading global pharmaceutical solutions organization, announced that it will release its financial results for the Second Quarter of Fiscal 2026 on Wednesday, May 6, 2026, prior to the opening of trading on the New York Stock Exchange. The company will host a conference call that same day at 8:30 a.m. ET to discuss the quarterly results.

Why it matters

As one of the largest pharmaceutical companies in the world, Cencora's quarterly earnings reports provide important insights into the overall health of the pharmaceutical industry and the company's own business performance. The earnings call will give investors, analysts, and the public a chance to hear directly from Cencora's leadership about the company's latest financial results and strategic priorities.

The details

Cencora plans to release its Q2 2026 financial results on May 6, 2026 before the market opens. The company will then host a conference call at 8:30 a.m. ET that same day to discuss the quarterly performance. Participating in the call will be Cencora's President & CEO Robert P. Mauch and Executive VP & CFO James F. Cleary.

  • Cencora will release Q2 2026 financial results on May 6, 2026.
  • Cencora will host an earnings conference call at 8:30 a.m. ET on May 6, 2026.

The players

Cencora, Inc.

A leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world.

Robert P. Mauch

President & Chief Executive Officer of Cencora.

James F. Cleary

Executive Vice President & Chief Financial Officer of Cencora.

Got photos? Submit your photos here. ›

What’s next

A replay of the webcast will be posted on investor.cencora.com approximately one hour after the completion of the call and will remain available for one year.

The takeaway

Cencora's upcoming earnings report will provide valuable insights into the state of the pharmaceutical industry and the company's own performance as one of the largest players in the market. The conference call will give investors and analysts a chance to hear directly from Cencora's leadership about the company's latest financial results and strategic priorities.